Application of French prognostic score to patients with International Prognostic Scoring System intermediate-2 or high risk myelodysplastic syndromes treated with 5-azacitidine is able to predict overall survival and rate of response

被引：15
|
作者：
Breccia, Massimo [1 ]
Loglisci, Giuseppina [1 ]
Cannella, Laura [1 ]
Finsinger, Paola [1 ]
Mancini, Marco [1 ]
Serrao, Alessandra [1 ]
Santopietro, Michelina [1 ]
Salaroli, Adriano [1 ]
Alimena, Giuliana [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00161 Rome, Italy
来源：
LEUKEMIA & LYMPHOMA | 2012年 / 53卷 / 05期
关键词：
AZACITIDINE;
D O I：
10.3109/10428194.2011.643408
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：985 / 986
页数：2
相关论文
共 26 条
  • [1] Comparison of the prognostic utility of the revised International Prognostic Scoring System and the French Prognostic Scoring System in azacitidine-treated patients with myelodysplastic syndromes
    Zeidan, Amer M.
    Lee, Ju-Whei
    Prebet, Thomas
    Greenberg, Peter
    Sun, Zhuoxin
    Juckett, Mark
    Smith, Mitchell R.
    Paietta, Elisabeth
    Gabrilove, Janice
    Erba, Harry P.
    Tallman, Martin S.
    Gore, Steven D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (03) : 352 - 359
  • [2] The Prognostic Value of Monosomal Karyotype (MK) in High-Risk Patients with Myelodysplastic Syndromes Treated with 5-Azacitidine
    Papageorgiou, Sotirios
    Kontos, Christos K.
    Tsiambalis, Thomas
    Vyniou, Athina
    Symeonidis, Argiris
    Galanopoulos, Athanasios
    Kotsianidis, Ioannis
    Pappa, Vassiliki
    BLOOD, 2017, 130
  • [3] Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine
    Itzykson, Raphael
    Thepot, Sylvain
    Quesnel, Bruno
    Dreyfus, Francois
    Beyne-Rauzy, Odile
    Turlure, Pascal
    Vey, Norbert
    Recher, Christian
    Dartigeas, Caroline
    Legros, Laurence
    Delaunay, Jacques
    Salanoubat, Celia
    Visanica, Sorin
    Stamatoullas, Aspasia
    Isnard, Francoise
    Marfaing-Koka, Anne
    de Botton, Stephane
    Chelghoum, Youcef
    Taksin, Anne-Laure
    Plantier, Isabelle
    Ame, Shanti
    Boehrer, Simone
    Gardin, Claude
    Beach, C. L.
    Ades, Lionel
    Fenaux, Pierre
    BLOOD, 2011, 117 (02) : 403 - 411
  • [4] EXPERIENCE WITH 5-AZACITIDINE IN PATIENTS DIAGNOSED BY MYELODYSPLASTIC SYNDROMES OF INTERMEDIATE 2/HIGH RISK
    Llorente Dunia, De Miguel
    Lopez Nuria, Golbano
    Morfa Miguel, Diaz
    Juanis Jaime, Arbeteta
    Sanz Dolores, Morales
    Ramo Alejandro, Vazquez
    Maqueda Cristina, Fernandez
    Garcia Helga, Guillen
    Perez Dolores, Subira
    Martin Sonia, Herrero
    Albiz Blanca, Pinedo
    HAEMATOLOGICA, 2016, 101 : 341 - 341
  • [5] FLOW CYTOMETRY PREDICTS TREATMENT OUTCOME IN INTERMEDIATE-2 AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS TREATED WITH 5-AZACITIDINE
    Alhan, C.
    Westers, T.
    Cali, C.
    Eeltink, C.
    Ossenkoppele, G.
    van de Loosdrecht, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 379 - 380
  • [6] CLINICAL VALUE OF MONOSOMAL KARYOTYPE AND COMPLEX KARYOTYPE AS PROGNOSTIC PARAMETER IN PATIENTS WITH IPSS INTERMEDIATE-2 AND HIGH RISK MYELODYSPLASTIC SYNDROMES TREATED WITH AZACITIDINE
    Song, M. K.
    Chung, J. S.
    Moon, J. H.
    Ahn, J. S.
    Song, I. C.
    Hong, J.
    Lee, G. W.
    Shin, H. J.
    HAEMATOLOGICA, 2014, 99 : 346 - 346
  • [7] Monosomal and complex karyotypes as prognostic parameters in patients with International Prognostic Scoring System higher risk myelodysplastic syndrome treated with azacitidine
    Hwang, Kyung-Lim
    Song, Moo-Kon
    Shin, Jin
    Na, Hae-Jung
    Shin, Dong-Hun
    Kim, Joong-Keun
    Moon, Joon-Ho
    Ahn, Jae-Sook
    Song, Ik-Chan
    Hong, Junshik
    Lee, Gyeong-won
    Chung, Joo-Seop
    BLOOD RESEARCH, 2014, 49 (04) : 234 - 240
  • [8] Flow Cytometric Score Correlates with Clinical Response to Azacitidine In Intermediate-2 and High Risk Myelodysplastic Syndrome Patients
    Alhan, Canan
    Westers, Theresia M.
    Eeltink, Corien
    Cali, Claudia
    Ossenkoppele, Gert J.
    Van de Loosdrecht, Arjan A.
    BLOOD, 2010, 116 (21) : 198 - 198
  • [9] Application of the French Prognostic Score to assess overall survival in a US-based cohort of patients treated with azacitidine
    Zeidan, A.
    Zhuoxin, S.
    Prebet, T.
    Greenberg, P.
    Juckett, M.
    Smith, M.
    Paietta, E.
    Gabrilove, J.
    Erba, H.
    Gore, S.
    Tallman, M.
    LEUKEMIA RESEARCH, 2013, 37 : S79 - S80
  • [10] The prognostic value of monosomal karyotype (MK) in higher-risk patients with myelodysplastic syndromes treated with 5-Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group
    Papageorgiou, Sotirios G.
    Vasilatou, Diamantina
    Kontos, Christos K.
    Kotsianidis, Ioannis
    Symeonidis, Argiris
    Galanopoulos, Athanasios G.
    Hatzimichael, Eleftheria
    Megalakaki, Aekaterini
    Poulakidas, Elias
    Diamantopoulos, Panagiotis
    Vassilakopoulos, Theodoros P.
    Zikos, Panagiotis
    Papadaki, Helen
    Mparmparousi, Despoina
    Bouronikou, Eleni
    Panayiotidis, Panayiotis
    Viniou, Nora-Athina
    Pappa, Vassiliki
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (07) : 895 - 901
123